Serious reactions during malaria prophylaxis with pyrimethamine-sulfadoxine.
D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced; D000962:Antimalarials / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008288:Malaria / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced; D011739:Pyrimethamine / Q000009:adverse effects*; D013262:Stevens-Johnson Syndrome / Q000209:etiology; D013413:Sulfadoxine / Q000009:adverse effects*; D013424:Sulfanilamides / Q000009:adverse effects*
D000962:Antimalarials; D004338:Drug Combinations; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; D011739:Pyrimethamine